Glaukos Corporation (NYSE:GKOS) reported three-year trial results for its non-invasive keratoconus treatment while ...

Epioxa, an epithelium-on corneal cross-linking therapy for keratoconus, demonstrated positive outcomes in visual acuity, ...

Glaukos recently reported positive topline results from a long-term Phase 3 extension study of Epioxa, showing three-year ...

Oct 7 (Reuters) - Glaukos said on Wednesday patients treated with its late-stage eye disease therapy maintained improvements ...

Through his foundation and a paid partnership, Curry raises awareness about keratoconus, which he was diagnosed with in the 2018-19 season.

Golden State Warriors Stephen Curry, widely regarded as the greatest shooter in basketball history, discusses his journey with keratoconus, a progressive eye disorder.

Normally, your cornea— the clear outer lens or "windshield" of your eye — has a dome shape, like a ball. Sometimes, the structure isn’t strong enough to hold its round shape and bulges outward, like a ...

Three-year data demonstrate sustained improvements in corneal shape, meaningful visual acuity gains, and a favorable ...

Glaukos Corporation (NYSE: GKOS) announced results from a long-term Phase 3 extension study evaluating its Epioxa corneal cross-linking therapy for keratoconus, showing sustained efficacy and safety ...

K: Keratometry; SE: Spheric equivalent. Intracorneal ring segments of smaller size and greater thickness provide a more corrective effect. Intracorneal ring segment (ICRS) implantation can be ...

The Golden State Warriors star has opened up about being diagnosed with keratoconus, an eye condition that can cause blurred or distorted vision as the cornea thins and begins to bulge outward. Curry ...